Co-Payment Assistance Granted $46M to Prostate Cancer Patients in 2014

Co-Payment Assistance Granted $46M to Prostate Cancer Patients in 2014
During 2014, the non-profit organization The End of Prostate Cancer granted more than $46 million to 12,000 patients suffering from prostate cancer in the form of co-payment assistance and education programs being conducted in collaboration with The Patient Access Network (PAN) Foundation. The two organizations have worked together to reduce the burden on prostate cancer patients, and have managed to expand the program for 2015, as announced in a press release. Working in partnership since 2013, The End of Prostate Cancer and the PAN Foundation are particularly focused on offering comprehensive support to patients diagnosed with metastatic castrate resistant prostate cancer (mCRPC).  "There are more than two million prostate cancer patients in the U.S. today and too many of them are cut off from affording treatments they desperately need to fight the disease," explained Jamie Bearse, the CEO of ZERO – The End of Prostate Cancer. "Our partnership with the PAN Foundation helps to stop the pain and suffering due to prostate cancer by providing education and support to thousands of patients with advanced disease," Bearse added. The co-payment program is the result of a union of the already existing financial assistance program from the PAN Foundation with the educational resources for both patients and healthcare professionals provided by The End of Prostate Cancer. "Especially with the growth of high-deductible, high-copay health insurance plans, prostate cancer patients are facing greater challenges than ever affording their prescribed medications. Working together, the PAN Foundation and ZERO offer essential financial assistance and support services to these patients," stated the president and CEO of the PAN Foundation, Daniel Klein. Addit
Subscribe or to access all post and page content.